The novel agent PRIMA-1(met) can reactivate WTp53 function in MTp53-expressing cells. We investigated PRIMA-1(met) as a radiosensitizer of WTp53, p53Null or MTp53 prostate cancer cells. Radiosensitization was observed in PC3 (p53Null) cells, even under hypoxia. In certain circumstances, PRIMA-1(met) may therefore act independently of MTp53 status and WTp53 transactivation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.radonc.2008.01.001 | DOI Listing |
Publication Analysis
Top Keywords
prostate cancer
8
cancer cells
8
prima-1met
4
prima-1met radiosensitizes
4
radiosensitizes prostate
4
cells
4
cells independent
4
independent mtp53-status
4
mtp53-status novel
4
novel agent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!